Incentivizing biomedical innovation
Pennsylvania has long been a leader in healthcare research, medical technology and life sciences. My office recently hosted a regional symposium, “The Future of Healthcare,” and what we heard was a clear appeal for patient-centered reform that keeps up with modern, safe and intelligent technology. To remain competitive and attract new investment, we must continue creating an environment where innovation can thrive.
This is why I support bipartisan legislation to incentivize biomedical innovation, helping Pennsylvania attract cutting-edge research, create high-quality jobs, and accelerate the development of new treatments and technologies. Strengthening our biomedical sector is not only smart economic policy, it’s an important step toward improving healthcare outcomes for patients across the Commonwealth.
Strengthening accountability for health insurance CEOs
I am also supporting legislation with Rep. Emily Kinkead that would hold healthcare CEOs accountable when corporate decisions put profits ahead of patients. Far too many Pennsylvanians have experienced delayed treatments, denied claims, or unnecessary barriers to medically necessary care because insurance companies chose to prioritize their bottom line over patient well-being.
Healthcare decisions should be driven by doctors and patients, not corporate executives focused on earnings. Pennsylvanians should expect accountability from insurers and healthcare corporations, and that patient care must come first.